References
1. National Institute for Health and Care Excellence (NICE). Cow’s Milk Protein Allergy Manchester, UK: NICE; 2015. [Last accessed November 2017]
2. Grimshaw, K. et al. Clin Transl Allergy. 2016;6:1.
3. Fiocchi, A. et al. World Allergy Organ J. 2010; 3:57-161.
4. Luyt, D. et al. Clinical & Experimental Allergy. 2014; 44, 642–672.
5. Host, A. & Halken, S. Endocr Metab Immun Disord – Drug Targets. 2014; 14: 2-8.
6. National Institute for Health and Clinical Excellence, NICE: Diagnosis and assessment of food allergy in children and young people in primary care and community settings. London; 2011. [Last accessed November 2017]
7. Fox, A., Brown, T., Walsh, J. et al. An update to the Milk Allergy in Primary Care guideline. Clin Transl Allergy 9, 40 (2019) doi:10.1186/s13601-019-0281-8
8. Paediatric Group Position Statement. Use of Infant Formulas based on soy protein. The British Dietetic Association, update April 2019
9. Rapp, M. et al. Clin Transl Allergy. 2013; 3(3):132.
10. Niggemann, B. et al. Pediatr Allergy Immunol. 2008;194(4):348-54.
11. Bach, A.C. & Babayan, V.K. Am J Clin Nutr. 1982;36: 950-962.
12. Nutritional Information from Product Data Cards: Aptamil Pepti®, Nutramigen with LGG® and Similac Alimentum®, July, 2020.
13. Allergy UK. (2016). The iMAP Milk Ladder. [Last accessed November 2017]
IMPORTANT NOTICE: The World Health Organisation (WHO) has recommended that pregnant women and new mothers be informed on the benefits and superiority of breastfeeding - in particular the fact that it provides the best nutrition and protection from illness for babies. Mothers should be given guidance on the preparation for, and maintenance of, lactation, with special emphasis on the importance of a well-balanced diet both during pregnancy and after delivery. Unnecessary introduction of partial bottle-feeding or other foods and drinks should be discouraged since it will have a negative effect on breastfeeding. Similarly, mothers should be warned of the difficulty of reversing a decision not to breastfeed. Before advising a mother to use an infant formula, she should be advised of the social and financial implications of her decision: for example, if a baby is exclusively bottle-fed, more than one can (400 g) per week will be needed, so the family circumstances and costs should be kept in mind. Mothers should be reminded that breast milk is not only the best, but also the most economical food for babies. Mothers should be encouraged to continue breastfeeding even when their infants have CMPA. This usually requires qualified dietary counselling to completely exclude all sources of cows’ milk protein from the mother’s diet. If a decision to use a special formula intended for infants is taken, it is important to give instructions on correct preparation methods, emphasising that unboiled water, unsterilised bottles or incorrect dilution can all lead to illness. Formula for special medical purposes intended for infants must be used under medical supervision. SMA® Wysoy® milk-free formula is intended to meet the nutritional needs of babies and children who are intolerant to cows’ milk protein, lactose or sucrose. Soya infant formulae are not recommended for preterm babies or those with kidney problems, where medical guidance should always be sought. The following products must be used under medical supervision: SMA® Alfamino® is a food for special medical purpose and is for complete nutritional support from birth or supplementary feeding from 6 months and up to 3 years of age for the dietary management of cows’ milk allergy, multiple food allergies and other conditions where an amino acid formula is recommended. SMA® Althera® is a food for special medical purpose and is for complete nutritional support from birth or supplementary feeding from 6 months and up to 3 years of age, for the dietary management of CMA and/or multiple food protein allergies.
ZTT672/09/2020
©2020 CIG Healthcare Partnership
SMA® Nutrition, UK
This communication has been approved by the NPA. The NPA will have no liability to any person or entity with liability, loss or damage caused or alleged to have been caused directly or indirectly by information therein. The NPA is not responsible for the content of any non-NPA websites mentioned in this programme or for the accuracy of any information found there. The fact that a website, organisation or product is mentioned in the programme does not mean that the NPA either approves of it or endorses it.